Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$5.91 USD
+0.16 (2.78%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $5.91 0.00 (0.00%) 5:24 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.39 | 0.00% |
Earnings Summary
For their last quarter, Black Diamond Therapeutics (BDTX) reported earnings of -$0.35 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 20.45%. Look out for BDTX's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.39 per share, reflecting a year-over-year increase of 25%.
Earnings History
Price & Consensus
Zacks News for BDTX
Black Diamond (BDTX) is on the Move, Here's Why the Trend Could be Sustainable
BDTX: What are Zacks experts saying now?
Zacks Private Portfolio Services